Isabelle To
Contact
Office Phone:
Email:
Related Sites:
About
Teaching and Supervision
PMPR 442: Introduction to Specialty Pharmacy (442), 10/3/2025 – 10/10/2025
PMPR 442: Introduction to Specialty Pharmacy (442), 10/4/2024 – 10/11/2024
Managed Care Pharmacy (383), 3/13/2024 – 3/13/2024
PMPR 442: Introduction to Specialty Pharmacy (385), 9/28/2023 – 10/4/2023
Selected Publications
To, Isabelle. (2025). Making Sense of the Adalimumab Biosimilars – 2025 Update. Illinois Council of Health-System Pharmacists.
To, Isabelle, Kumor, Lisa, Swiatek, Jake, Monteiro, Andrea, Thomas, Karen. Development of a Pilot Sickle Cell Disease Clinical Dashboard in a Health System Specialty Pharmacy. Pending AJHP Resident Edition.
Professional Leadership
Identifying Outcome Measures for Specialty Pharmacists in IBD Using the Modified Delphi Method, 6/19/2025 - 10/25/2025
Adalimumab Biosimilar Implementation Among Health System Specialty Pharmacies, 10/21/2024 - Present
Adalimumab Biosimilar Formulary Changes Research, 4/30/2024 - Present
Identifying Outcome Measures for Specialty Pharmacists in Rheumatoid Arthritis Using the Modified Delphi Method, 4/1/2024 - 9/20/2024
Education
Degrees:
Doctorate of Pharmacy, University of Pittsburgh, United States, 2022
Postgraduate Training:
PGY1 Specialty Pharmacy Services Resident, University of Illinois at Chicago, United States, 2023
Selected Presentations
To, Isabelle, Bush, Fiona. (2026 March 14). From Brand to Biosimilar: Transforming Pharmacy with Emerging Biosimilars. ICHP Spring Meeting. Springfield, IL.
To, Isabelle. (2025 October 18). 2025 Biosimilar Update. IBD Pro. Chicago, IL.